Anti-tumour necrosis factor therapy in seronegative spondyloarthritis

Clin Med (Lond). 2005 May-Jun;5(3):219-22. doi: 10.7861/clinmedicine.5-3-219.
No abstract available

Publication types

  • Review

MeSH terms

  • Antirheumatic Agents / therapeutic use*
  • Clinical Trials as Topic
  • Humans
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Rheumatoid Factor / immunology*
  • Spondylarthritis / drug therapy*
  • Spondylarthritis / immunology*
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antirheumatic Agents
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Rheumatoid Factor